Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Labetalol vs Dexmedetomidine in ENT Hypotensive Anesthesia
NCT06752863Phase 4Recruiting
- Sponsor
- Ain Shams University
- Start
- Nov 2024
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of labetalol, dexmedetomidine in hypotension, sponsored by Ain Shams University. Started Nov 2024; status: recruiting.
02
Drugs
labetaloldexmedetomidine
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT06752863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06752863.